To evaluate the relationship between use of oral contraceptives and risk of invasive cervical cancer, a case-control study involving 479 patients and 789 population controls was undertaken in 5 geographic regions of the US. Initially, the relationship was obscured by confounding variables, particula
Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers
β Scribed by Allan Hildesheim; William C. Reeves; Louise A. Brinton; Carol Lavery; Maria Brenes; Maria Elena De La Guardia; Julio Godoy; William E. Rawls
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 584 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Within the context of a larger hospital-based case-control ment of subjects lasted from September 1,1983 through March study carried out to assess the efficacy of cervical cancer 31. 1985. screening, the possible association between oral contracep-+he series comprises 129 with newly diagnosed tives
## Abstract In a caseβcontrol study conducted in Latin America, the relationship of injectable contraceptive (IC) use to risk of in vasive cervical cancer was analyzed while controlling for a variety of other risk factors, including female and spouse sexual behavior and infection with human papillo
An integrated study on the role of human papillomaviruses (HPV) in cervical cancer has been conducted. Out of a total of 433 cases of cervical cancer, HPV-DNA was detected in 342 (79%) using the polymerase chain reaction (PCR). The incidence of HPV infection was not significantly related to histolog
Human papillomavirus (HPV) types 16 and 18 have been implicated as risk factors for cervical dysplasia and neoplasia. However, most studies have been observational, uncontrolled and conducted in populations at low risk for invasive cancer. We report a pilot case-control study of incident invasive ce
One hundred and seventy four (81% of all) pathologically confirmed new incident cases of female breast cancer identified from a medical center in Taipei from February, 1993 to June, 1994 were selected as the case group. Four hundred and fifty three inpatient controls who were without obstetricgyneco